
MassHealth ends GLP-1 obesity coverage, affecting thousands statewide
MassHealth will stop covering GLP-1 weight‑loss medications starting Friday, affecting about 22,000 Medicaid beneficiaries (including roughly 2,500 children). Coverage remains for diabetes or obesity with certain medical conditions. The move is projected to save about $15 million but risks weight regain and worsened health for those losing access, leaving some to go without treatment, pay out of pocket, or seek cheaper alternatives; under‑21 coverage remains only with medical necessity.


